Additionally, TRPV1 upregulation has been documented in multiple types of human breast carcinoma compared to healthy tissue, whereas, in murine models, TRPV1 downregulation has been linked to an increased risk of developing colon carcinoma and urothelial carcinoma progression [16]. Here, TRPV1 is linked to urothelial carcinoma.